Amelioration of diabetes by imatinib mesylate (Gleevec): role of beta-cell NF-kappaB activation and anti-apoptotic preconditioning.

Source:http://linkedlifedata.com/resource/pubmed/id/17135364

Download in:

View as

General Info

PMID
17135364